Genome-wide identification and analysis of prognostic features in human cancers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-wide identification and analysis of prognostic features in human cancers
Authors
Keywords
cancer genomics, biomarkers, drug targets
Journal
Cell Reports
Volume 38, Issue 13, Pages 110569
Publisher
Elsevier BV
Online
2022-03-29
DOI
10.1016/j.celrep.2022.110569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies
- (2021) Devon A. Lukow et al. DEVELOPMENTAL CELL
- Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer
- (2020) Anand Vasudevan et al. DEVELOPMENTAL CELL
- SciPy 1.0: fundamental algorithms for scientific computing in Python
- (2020) Pauli Virtanen et al. NATURE METHODS
- Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis
- (2020) Leitao Sun et al. Scientific Reports
- Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases
- (2020) Philip C. Mack et al. CANCER
- Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
- (2020) Steven D. Green et al. Frontiers in Genetics
- Discovering and validating cancer genetic dependencies: approaches and pitfalls
- (2020) Ann Lin et al. NATURE REVIEWS GENETICS
- Array programming with NumPy
- (2020) Charles R. Harris et al. NATURE
- g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
- (2019) Uku Raudvere et al. NUCLEIC ACIDS RESEARCH
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Aneuploidy drives lethal progression in prostate cancer
- (2019) Konrad H. Stopsack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erdafitinib: First Global Approval
- (2019) Anthony Markham DRUGS
- Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
- (2019) Ann Lin et al. Science Translational Medicine
- Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
- (2019) Kil-yong Lee et al. Scientific Reports
- A Comparative Analysis of Individual RAS Mutations in Cancer Biology
- (2019) Carmen Muñoz-Maldonado et al. Frontiers in Oncology
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- The emerging clinical relevance of genomics in cancer medicine
- (2018) Michael F. Berger et al. Nature Reviews Clinical Oncology
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
- (2018) Haley Hieronymus et al. eLife
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- GENCODE reference annotation for the human and mouse genomes
- (2018) Adam Frankish et al. NUCLEIC ACIDS RESEARCH
- Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
- (2018) Joan C Smith et al. eLife
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications
- (2017) D Amar et al. ONCOGENE
- Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study
- (2017) Sabrina Jegerlehner et al. PLoS One
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
- (2017) Emmet J. Jordan et al. Cancer Discovery
- Kinetic Analysis of Protein Stability Reveals Age-Dependent Degradation
- (2016) Erik McShane et al. CELL
- Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
- (2016) Rosie Elizabeth Ann Gutteridge et al. MOLECULAR CANCER THERAPEUTICS
- Interobserver variability in Gleason histological grading of prostate cancer
- (2016) Tayyar A. Ozkan et al. Scandinavian Journal of Urology
- A pan-cancer analysis of prognostic genes
- (2016) Jordan Anaya et al. PeerJ
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer
- (2016) Ran Zhao et al. EBioMedicine
- Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
- (2015) Joann G. Elmore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma
- (2015) Arun M Unni et al. eLife
- Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
- (2014) H. R. Ali et al. ANNALS OF ONCOLOGY
- The past and future of CD33 as therapeutic target in acute myeloid leukemia
- (2014) George S. Laszlo et al. BLOOD REVIEWS
- Overdiagnosis and Overtreatment of Prostate Cancer
- (2014) Stacy Loeb et al. EUROPEAN UROLOGY
- Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
- (2014) Y Aye et al. ONCOGENE
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A Transcriptional and Metabolic Signature of Primary Aneuploidy Is Present in Chromosomally Unstable Cancer Cells and Informs Clinical Prognosis
- (2013) J. M. Sheltzer CANCER RESEARCH
- ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
- (2013) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- DNA methylation profiles of long- and short-term glioblastoma survivors
- (2013) Thoraia Shinawi et al. Epigenetics
- Overdiagnosis and Overtreatment in Cancer
- (2013) Laura J. Esserman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
- (2012) W. C. Reinhold et al. CANCER RESEARCH
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Is DCIS Breast Cancer, and How Do I Treat it?
- (2012) N. Bijker et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs
- (2012) A. Jarmula MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
- (2011) David Venet et al. PLoS Computational Biology
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?
- (2009) Jennifer R. Stark et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcomes and Correlates of TP53 Mutations and Cancer
- (2009) A. I. Robles et al. Cold Spring Harbor Perspectives in Biology
- Interobserver Variability Between Expert Urologic Pathologists for Extraprostatic Extension and Surgical Margin Status in Radical Prostatectomy Specimens
- (2008) Andrew J. Evans et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists
- (2008) Jonathan D Mosley et al. BMC Medical Genomics
- Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
- (2008) Jan P. A. Baak et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation